B
Biohaven Ltd.
BHVN · NYSE · Healthcare · 2.2B
Closing price
$12.08
+1.26% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
25.0×
Enterprise value / EBITDAEV/EBITDA
-1.9×
Free cash flow yieldFCF yield
-46.9%
Return on equityROE
-1418.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.